Breast Ductal Carcinoma — Trials

Breast Ductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 60
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02856503	Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors	withdrawn	Phase 1 / Phase 2	0	Eli Avisar, MDOTHER	0	Apr 17, 2026	clinicaltrials
NCT04985357	Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs	withdrawn	—	0	Travera IncINDUSTRY	0	Nov 25, 2024	clinicaltrials